{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T01:01:50Z","timestamp":1787965310638,"version":"build-2784847793"},"reference-count":93,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2018,7,18]],"date-time":"2018-07-18T00:00:00Z","timestamp":1531872000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,10,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The incidence of celiac disease has risen quickly and has a worldwide distribution in Europe, North and South America, Asia, the Middle East and Africa. This is attributed in part to increased availability in screening but also to the fast-rising gluten consumption and perhaps unknown environmental factors. In daily practice, this means that more subclinical cases and very young and elderly patients are diagnosed. The pathogenesis of celiac disease is a T-cell driven process initiated by gluten, leading to increased intestinal permeability and villous atrophy. The process requires HLA genotypes DQ2, DQ8 or both. Additional non-HLA alleles have been identified in genome-wide association studies. Serological testing, followed by duodenal biopsies, are still required to confirm the diagnosis. Advances are in the making for novel biomarkers to monitor disease and for pharmacological support of celiac disease. Medical costs and patient-perceived disease burden remain high in celiac disease, which point to the need for ongoing research in drug development to improve quality of daily life. Drugs undergoing phase I and phase II clinical trials include intraluminal therapies and vaccines to restore immune tolerance. These therapies aim to reduce symptoms and mucosal injuries as adjunct therapies to a gluten-free diet.<\/jats:p>","DOI":"10.1093\/jcag\/gwy042","type":"journal-article","created":{"date-parts":[[2018,7,4]],"date-time":"2018-07-04T18:51:38Z","timestamp":1530730298000},"page":"161-169","source":"Crossref","is-referenced-by-count":5,"title":["Celiac Disease: Against the Grain in Gastroenterology"],"prefix":"10.1093","volume":"2","author":[{"given":"Julie","family":"Zhu","sequence":"first","affiliation":[{"name":"Division of Gastroenterology, University of Alberta, Edmonton, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris J J","family":"Mulder","sequence":"additional","affiliation":[{"name":"Celiac Center Amsterdam, Department Gastroenterology and Hepatology, VU University Medical Center, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levinus A","family":"Dieleman","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, University of Alberta, Edmonton, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,7,18]]},"reference":[{"issue":"7","key":"2019101003041681100_CIT0001","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1586\/17474124.2015.1033399","article-title":"Celiac disease 2015 update: New therapies","volume":"9","author":"Veeraraghavan","year":"2015","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"1","key":"2019101003041681100_CIT0002","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/MPG.0000000000001312","article-title":"Celiac disease and wheat intolerance syndrome: A critical update and reappraisal","volume":"64","author":"Jericho","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"12","key":"2019101003041681100_CIT0003","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1001\/jama.2016.10395","article-title":"Screening for celiac disease: Evidence report and systematic review for the US preventive services task force","volume":"317","author":"Chou","year":"2017","journal-title":"JAMA"},{"key":"2019101003041681100_CIT0004","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1053\/j.gastro.2005.02.008","article-title":"Overview and pathogenesis of celiac disease","volume":"128","author":"Kagnoff","year":"2005","journal-title":"Gastroenterology"},{"issue":"11","key":"2019101003041681100_CIT0005","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1001\/jama.287.11.1413","article-title":"Risk of non-Hodgkin lymphoma in celiac disease","volume":"287","author":"Catassi","year":"2002","journal-title":"JAMA"},{"issue":"10","key":"2019101003041681100_CIT0006","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nrgastro.2015.131","article-title":"Extraintestinal manifestations of coeliac disease","volume":"12","author":"Leffler","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"2019101003041681100_CIT0007","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jaut.2008.06.001","article-title":"Co-occurrence of celiac disease and other autoimmune diseases in celiacs and their first-degree relatives","volume":"31","author":"Neuhausen","year":"2008","journal-title":"J Autoimmun"},{"issue":"3","key":"2019101003041681100_CIT0008","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.bpg.2015.05.004","article-title":"Celiac disease from a global perspective","volume":"29","author":"Lionetti","year":"2015","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"6670","key":"2019101003041681100_CIT0009","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/bmj.298.6670.387","article-title":"History of coeliac disease","volume":"298","author":"Smits","year":"1989","journal-title":"BMJ"},{"key":"2019101003041681100_CIT0010","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0065-3101(22)00464-9","article-title":"Celiac disease","volume":"9","author":"Dicke","year":"1957","journal-title":"Adv Pediatr"},{"key":"2019101003041681100_CIT0011","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-91316-2","article-title":"Global prevalence of celiac disease: Systematic review and meta-analysis","author":"Singh","year":"2018 ;16(6):823\u2013836","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"2019101003041681100_CIT0012","doi-asserted-by":"crossref","first-page":"441","DOI":"10.15403\/jgld.2014.1121.254.gil","article-title":"Celiac disease in The Netherlands: Demographic data of members of the Dutch Celiac society","volume":"25","author":"van Gils","year":"2016","journal-title":"J Gastrointestin Liver Dis"},{"key":"2019101003041681100_CIT0013","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1097\/01.mpg.0000450393.23156.59","article-title":"The new epidemiology of celiac disease","volume":"59","author":"Catassi","year":"2014","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"3","key":"2019101003041681100_CIT0014","doi-asserted-by":"crossref","first-page":"e0152476","DOI":"10.1371\/journal.pone.0152476","article-title":"Identification of non-HLA genes associated with celiac disease and country-specific differences in a large, international pediatric cohort","volume":"11","author":"Sharma","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"2019101003041681100_CIT0015","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1111\/jgh.13270","article-title":"Prevalence of celiac disease in Asia: A systematic review and meta-analysis","volume":"31","author":"Singh","year":"2016","journal-title":"J Gastroenterol Hepatol"},{"key":"2019101003041681100_CIT0016","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2017.02.012","article-title":"Lower prevalence of Celiac disease and gluten-related disorders in persons living in Southern vs Northern latitudes of the United States","author":"Unalp-Arida","year":"2017;152(8):1922\u20131932","journal-title":"Gastroenterology"},{"issue":"1","key":"2019101003041681100_CIT0017","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13073-015-0196-5","article-title":"Genomic prediction of celiac disease targeting HLA-positive individuals","volume":"7","author":"Abraham","year":"2015","journal-title":"Genome Med"},{"key":"2019101003041681100_CIT0018","article-title":"Changes in presentation of Celiac disease in Ireland from the 1960s to 2015","author":"Dominguez Castro","year":"2016;15(6):864\u2013871","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2019101003041681100_CIT0019","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/jgh.13704","article-title":"Coeliac disease in the 21st century: Paradigm shifts in the modern age","volume":"32","author":"Newnham","year":"2017","journal-title":"J Gastroenterol Hepatol"},{"issue":"45","key":"2019101003041681100_CIT0020","doi-asserted-by":"crossref","first-page":"6911","DOI":"10.3748\/wjg.14.6911","article-title":"Adult celiac disease in the elderly","volume":"14","author":"Freeman","year":"2008","journal-title":"World J Gastroenterol"},{"key":"2019101003041681100_CIT0021","doi-asserted-by":"crossref","DOI":"10.1097\/MPG.0000000000001532","article-title":"Increasing incidence and altered presentation in a population-based study of pediatric Celiac disease in North America","author":"Almallouhi","year":"2017;65(4):432\u2013437","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"42","key":"2019101003041681100_CIT0022","doi-asserted-by":"crossref","first-page":"e1779","DOI":"10.1097\/MD.0000000000001779","article-title":"Serological screening for Celiac disease in adult Chinese patients with diarrhea predominant irritable bowel syndrome","volume":"94","author":"Wang","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"2019101003041681100_CIT0023","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/ajg.2015.398","article-title":"Prevalence of adult celiac disease in India: Regional variations and associations","volume":"111","author":"Ramakrishna","year":"2016","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"2019101003041681100_CIT0024","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1111\/j.1440-1746.2010.06606.x","article-title":"Prevalence of celiac disease in the northern part of India: A community based study","volume":"26","author":"Makharia","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"issue":"5","key":"2019101003041681100_CIT0025","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1155\/2005\/203028","article-title":"Characteristics of primary biliary cirrhosis in British Columbia\u2019s First Nations population","volume":"19","author":"Arbour","year":"2005","journal-title":"Can J Gastroenterol"},{"issue":"1","key":"2019101003041681100_CIT0026","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/gut.42.1.120","article-title":"The association between primary biliary cirrhosis and coeliac disease: A study of relative prevalences","volume":"42","author":"Kingham","year":"1998","journal-title":"Gut"},{"issue":"8","key":"2019101003041681100_CIT0027","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1155\/2015\/927458","article-title":"Prevalence of celiac disease and celiac autoimmunity in the Toba Native Amerindian community of Argentina","volume":"29","author":"Vazquez","year":"2015","journal-title":"Can J Gastroenterol Hepatol"},{"key":"2019101003041681100_CIT0028","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1053\/j.gastro.2005.02.021","article-title":"Should adults be screened for celiac disease? What are the benefits and harms of screening","volume":"128","author":"Collin","year":"2005","journal-title":"Gastroenterology"},{"issue":"10","key":"2019101003041681100_CIT0029","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1111\/apt.14625","article-title":"Natural history and clinical detection of undiagnosed coeliac disease in a North American community","volume":"47","author":"Hujoel","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"2019101003041681100_CIT0030","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/MPG.0b013e31821a23d0","article-title":"European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease","volume":"54","author":"Husby","year":"2012","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"5","key":"2019101003041681100_CIT0031","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/ajg.2013.79","article-title":"ACG clinical guidelines: Diagnosis and management of celiac disease","volume":"108","author":"Rubio-Tapia","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"2019101003041681100_CIT0032","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1097\/MCG.0b013e31824b2277","article-title":"Immunoglobulin A deficiency in celiac disease","volume":"46","author":"Chow","year":"2012","journal-title":"J Clin Gastroenterol"},{"issue":"6","key":"2019101003041681100_CIT0033","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1136\/jcp.2004.023978","article-title":"Coeliac disease","volume":"58","author":"Corazza","year":"2005","journal-title":"J Clin Pathol"},{"issue":"9","key":"2019101003041681100_CIT0034","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1007\/s10620-014-3143-1","article-title":"Clinical utility of celiac disease-associated HLA testing","volume":"59","author":"Pallav","year":"2014","journal-title":"Dig Dis Sci"},{"key":"2019101003041681100_CIT0035","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1471-230X-9-78","article-title":"Importance of duodenal bulb biopsies in children for diagnosis of celiac disease in clinical practice","volume":"9","author":"Rashid","year":"2009","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"2019101003041681100_CIT0036","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/0016-5085(92)91819-P","article-title":"Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity (\u2018celiac sprue\u2019)","volume":"102","author":"Marsh","year":"1992","journal-title":"Gastroenterology"},{"issue":"4","key":"2019101003041681100_CIT0037","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/j.1572-0241.1999.983_f.x","article-title":"Sensitivity of antiendomysium and antigliadin antibodies in untreated celiac disease: Disappointing in clinical practice","volume":"94","author":"Rostami","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"2019101003041681100_CIT0038","doi-asserted-by":"crossref","DOI":"10.1111\/apt.14048","article-title":"Performing routine follow-up biopsy 1 year after diagnosis does not affect long-term outcomes in coeliac disease","author":"Pekki","year":"2017;45(11):1459\u20131468","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"2019101003041681100_CIT0039","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/apt.12164","article-title":"Mucosal healing and mortality in coeliac disease","volume":"37","author":"Lebwohl","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"2019101003041681100_CIT0040","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/apt.12621","article-title":"Predictors of persistent villous atrophy in coeliac disease: A population-based study","volume":"39","author":"Lebwohl","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"2019101003041681100_CIT0041","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1080\/00365521.2016.1218540","article-title":"Long-term mucosal recovery and healing in celiac disease is the rule\u2014not the exception","volume":"51","author":"Haere","year":"2016","journal-title":"Scand J Gastroenterol"},{"issue":"3","key":"2019101003041681100_CIT0042","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/MPG.0000000000001270","article-title":"Normalization time of celiac serology in children on a gluten-free diet","volume":"64","author":"Gidrewicz","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2019101003041681100_CIT0043","doi-asserted-by":"crossref","DOI":"10.1038\/ajg.2017.71","article-title":"Open-capsule budesonide for refractory celiac disease","author":"Mukewar","year":"2017;112(6):959\u2013967","journal-title":"Am J Gastroenterol"},{"key":"2019101003041681100_CIT0044","article-title":"High incidence of celiac disease in a long-term study of adolescents with susceptibility genotypes","author":"Liu","year":"2017;152(6):1329\u20131336","journal-title":"Gastroenterology"},{"key":"2019101003041681100_CIT0045","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.2337\/dcs15-2007","article-title":"Contrasting the genetic background of type 1 diabetes and celiac disease autoimmunity","volume":"38","author":"Gutierrez-Achury","year":"2015","journal-title":"Diabetes Care"},{"issue":"1","key":"2019101003041681100_CIT0046","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1056\/NEJMoa1313977","article-title":"Risk of pediatric celiac disease according to HLA haplotype and country","volume":"371","author":"Liu","year":"2014","journal-title":"N Engl J Med"},{"issue":"3","key":"2019101003041681100_CIT0047","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/apt.12373","article-title":"Systematic review: Worldwide variation in the frequency of coeliac disease and changes over time","volume":"38","author":"Kang","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"2019101003041681100_CIT0048","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1093\/hmg\/ddt619","article-title":"Fine mapping of the celiac disease-associated LPP locus reveals a potential functional variant","volume":"23","author":"Almeida","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"2","key":"2019101003041681100_CIT0049","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jcmgh.2016.12.006","article-title":"Celiac disease: Role of the epithelial barrier","volume":"3","author":"Schumann","year":"2017","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"3","key":"2019101003041681100_CIT0050","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/MOG.0000000000000343","article-title":"Optimizing the diagnosis of celiac disease","volume":"33","author":"Lau","year":"2017","journal-title":"Curr Opin Gastroenterol"},{"issue":"4","key":"2019101003041681100_CIT0051","first-page":"197","article-title":"Celiac disease serology in dermatitis herpetiformis. Which is the best option for detecting gluten sensitivity","volume":"36","author":"Sugai","year":"2006","journal-title":"Acta Gastroenterol Latinoam"},{"issue":"1\u20132","key":"2019101003041681100_CIT0052","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jneuroim.2010.09.024","article-title":"Serology of celiac disease in gluten-sensitive ataxia or neuropathy: Role of deamidated gliadin antibody","volume":"230","author":"Rashtak","year":"2011","journal-title":"J Neuroimmunol"},{"issue":"5","key":"2019101003041681100_CIT0053","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1572-0241.2003.07284.x","article-title":"Reliability of antitransglutaminase antibodies as predictors of gluten-free diet compliance in adult celiac disease","volume":"98","author":"Vahedi","year":"2003","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"2019101003041681100_CIT0054","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/00004836-200311000-00007","article-title":"Lack of usefulness of anti-transglutaminase antibodies in assessing histologic recovery after gluten-free diet in celiac disease","volume":"37","author":"Tursi","year":"2003","journal-title":"J Clin Gastroenterol"},{"issue":"8","key":"2019101003041681100_CIT0055","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.1038\/ctg.2017.41","article-title":"Clinical and histologic mimickers of celiac disease","volume":"8","author":"Kamboj","year":"2017","journal-title":"Clin Transl Gastroenterol"},{"issue":"10","key":"2019101003041681100_CIT0056","doi-asserted-by":"crossref","first-page":"e107312","DOI":"10.1371\/journal.pone.0107312","article-title":"Differentiating coeliac disease from irritable bowel syndrome by urinary volatile organic compound analysis\u2014a pilot study","volume":"9","author":"Arasaradnam","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"2019101003041681100_CIT0057","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/apt.12194","article-title":"Serum I-FABP as marker for enterocyte damage in coeliac disease and its relation to villous atrophy and circulating autoantibodies","volume":"37","author":"Adriaanse","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"2019101003041681100_CIT0058","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.3109\/00365521.2011.627447","article-title":"Additional value of serum I-FABP levels for evaluating celiac disease activity in children","volume":"46","author":"Vreugdenhil","year":"2011","journal-title":"Scand J Gastroenterol"},{"issue":"3","key":"2019101003041681100_CIT0059","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1136\/gut.34.3.354","article-title":"Intestinal permeability in patients with coeliac disease and relatives of patients with coeliac disease","volume":"34","author":"van Elburg","year":"1993","journal-title":"Gut"},{"key":"2019101003041681100_CIT0060","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1146\/annurev-immunol-040210-092915","article-title":"Integration of genetic and immunological insights into a model of celiac disease pathogenesis","volume":"29","author":"Abadie","year":"2011","journal-title":"Annu Rev Immunol"},{"issue":"6","key":"2019101003041681100_CIT0061","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1053\/j.gastro.2006.10.003","article-title":"AGA institute medical position statement on the diagnosis and management of celiac disease","volume":"131","author":"Institute","year":"2006","journal-title":"Gastroenterology"},{"issue":"5","key":"2019101003041681100_CIT0062","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/1521-4141(200105)31:5<1317::AID-IMMU1317>3.0.CO;2-I","article-title":"T cells from celiac disease lesions recognize gliadin epitopes deamidated in situ by endogenous tissue transglutaminase","volume":"31","author":"Molberg","year":"2001","journal-title":"Eur J Immunol"},{"issue":"1","key":"2019101003041681100_CIT0063","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/imr.12191","article-title":"IL-15: A central regulator of celiac disease immunopathology","volume":"260","author":"Abadie","year":"2014","journal-title":"Immunol Rev"},{"issue":"14","key":"2019101003041681100_CIT0064","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1056\/NEJMoa1400697","article-title":"Introduction of gluten, HLA status, and the risk of celiac disease in children","volume":"371","author":"Lionetti","year":"2014","journal-title":"N Engl J Med"},{"issue":"14","key":"2019101003041681100_CIT0065","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1056\/NEJMoa1404172","article-title":"Randomized feeding intervention in infants at high risk for celiac disease","volume":"371","author":"Vriezinga","year":"2014","journal-title":"N Engl J Med"},{"issue":"25","key":"2019101003041681100_CIT0066","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1056\/NEJMoa021687","article-title":"Prevalence of Celiac disease among children in Finland","volume":"348","author":"Maki","year":"2003","journal-title":"N Engl J Med"},{"issue":"4","key":"2019101003041681100_CIT0067","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1053\/j.gastro.2016.06.041","article-title":"Duodenal bacteria from patients with celiac disease and healthy subjects distinctly affect gluten breakdown and immunogenicity","volume":"151","author":"Caminero","year":"2016","journal-title":"Gastroenterology"},{"issue":"6333","key":"2019101003041681100_CIT0068","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1126\/science.aah5298","article-title":"Reovirus infection triggers inflammatory responses to dietary antigens and development of celiac disease","volume":"356","author":"Bouziat","year":"2017","journal-title":"Science"},{"issue":"10","key":"2019101003041681100_CIT0069","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1111\/j.1572-0241.2006.00741.x","article-title":"Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: A longitudinal study","volume":"101","author":"Stene","year":"2006","journal-title":"Am J Gastroenterol"},{"issue":"16","key":"2019101003041681100_CIT0070","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJM199510193331602","article-title":"A comparison of diets with and without oats in adults with celiac disease","volume":"333","author":"Janatuinen","year":"1995","journal-title":"N Engl J Med"},{"key":"2019101003041681100_CIT0071","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.coph.2015.09.002","article-title":"Pharmacological approaches in celiac disease","volume":"25","author":"McCarville","year":"2015","journal-title":"Curr Opin Pharmacol"},{"issue":"10","key":"2019101003041681100_CIT0072","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1038\/ajg.2012.211","article-title":"A randomized, double-blind study of larazotide acetate to prevent the activation of celiac disease during gluten challenge","volume":"107","author":"Leffler","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"2019101003041681100_CIT0073","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.peptides.2012.02.016","article-title":"Larazotide acetate promotes tight junction assembly in epithelial cells","volume":"35","author":"Gopalakrishnan","year":"2012","journal-title":"Peptides"},{"issue":"2","key":"2019101003041681100_CIT0074","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/apt.12147","article-title":"Larazotide acetate in patients with coeliac disease undergoing a gluten challenge: A randomised placebo-controlled study","volume":"37","author":"Kelly","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"2019101003041681100_CIT0075","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1053\/j.gastro.2015.02.008","article-title":"Larazotide acetate for persistent symptoms of celiac disease despite a gluten-free diet: A randomized controlled trial","volume":"148","author":"Leffler","year":"2015","journal-title":"Gastroenterology"},{"issue":"7","key":"2019101003041681100_CIT0076","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1053\/j.gastro.2014.02.031","article-title":"Glutenase ALV003 attenuates gluten-induced mucosal injury in patients with celiac disease","volume":"146","author":"Lahdeaho","year":"2014","journal-title":"Gastroenterology"},{"issue":"35","key":"2019101003041681100_CIT0077","doi-asserted-by":"crossref","first-page":"5837","DOI":"10.3748\/wjg.v19.i35.5837","article-title":"Consumption of gluten with gluten-degrading enzyme by celiac patients: A pilot-study","volume":"19","author":"Tack","year":"2013","journal-title":"World J Gastroenterol"},{"issue":"9","key":"2019101003041681100_CIT0078","first-page":"582","article-title":"Emerging therapeutic options for celiac disease: Potential alternatives to a gluten-free diet","volume":"8","author":"Bakshi","year":"2012","journal-title":"Gastroenterol Hepatol (N Y)"},{"issue":"2","key":"2019101003041681100_CIT0079","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/MCG.0b013e31827759ac","article-title":"Exploratory, randomized, double-blind, placebo-controlled study on the effects of Bifidobacterium infantis natren life start strain super strain in active celiac disease","volume":"47","author":"Smecuol","year":"2013","journal-title":"J Clin Gastroenterol"},{"issue":"2","key":"2019101003041681100_CIT0080","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jaci.2014.07.022","article-title":"Experimental hookworm infection and gluten microchallenge promote tolerance in celiac disease","volume":"135","author":"Croese","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"2019101003041681100_CIT0081","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2012.05154.x","article-title":"Tioguanine in the treatment of refractory coeliac disease\u2014a single centre experience","volume":"36","author":"Tack","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"2019101003041681100_CIT0082","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3748\/wjg.v17.i4.506","article-title":"Evaluation of Cladribine treatment in refractory celiac disease type II","volume":"17","author":"Tack","year":"2011","journal-title":"World J Gastroenterol"},{"issue":"11","key":"2019101003041681100_CIT0083","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.cgh.2006.07.007","article-title":"Cladribine therapy in refractory celiac disease with aberrant T cells","volume":"4","author":"Al-Toma","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"2019101003041681100_CIT0084","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1365-277X.2007.00763.x","article-title":"Economic burden of a gluten-free diet","volume":"20","author":"Lee","year":"2007","journal-title":"J Hum Nutr Diet"},{"issue":"2","key":"2019101003041681100_CIT0085","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/jgh.13060","article-title":"Adherence to the gluten-free diet can achieve the therapeutic goals in almost all patients with coeliac disease: A 5-year longitudinal study from diagnosis","volume":"31","author":"Newnham","year":"2016","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"2019101003041681100_CIT0086","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13073-016-0295-y","article-title":"The influence of a short-term gluten-free diet on the human gut microbiome","volume":"8","author":"Bonder","year":"2016","journal-title":"Genome Med"},{"issue":"4","key":"2019101003041681100_CIT0087","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1365-2036.2005.02574.x","article-title":"Is coeliac disease screening in risk groups justified? A fourteen-year follow-up with special focus on compliance and quality of life","volume":"22","author":"Viljamaa","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"2019101003041681100_CIT0088","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1053\/j.gastro.2009.03.059","article-title":"Increased prevalence and mortality in undiagnosed celiac disease","volume":"137","author":"Rubio-Tapia","year":"2009","journal-title":"Gastroenterology"},{"issue":"150","key":"2019101003041681100_CIT0089","first-page":"47154","article-title":"Food labeling: Gluten-free labeling of foods. Final rule","volume":"78","author":"Food, Drug Administration HHS","year":"2013","journal-title":"Fed Regist"},{"key":"2019101003041681100_CIT0090","doi-asserted-by":"crossref","DOI":"10.1111\/eci.12755","article-title":"Challenging in Gluten-free diet in celiac disease: Prague consensus","author":"Samasca","year":"2017","journal-title":"Eur J Clin Invest"},{"issue":"10","key":"2019101003041681100_CIT0091","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1007\/s10620-016-4219-x","article-title":"Direct costs in patients with celiac disease in the USA: A retrospective claims analysis","volume":"61","author":"Guandalini","year":"2016","journal-title":"Dig Dis Sci"},{"issue":"9","key":"2019101003041681100_CIT0092","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/ajg.2014.29","article-title":"Patient perception of treatment burden is high in celiac disease compared with other common conditions","volume":"109","author":"Shah","year":"2014","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"2019101003041681100_CIT0093","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1155\/2015\/508156","article-title":"Tax-deductible provisions for gluten-free diet in Canada compared with systems for gluten-free diet coverage available in various countries","volume":"29","author":"Pinto-Sanchez","year":"2015","journal-title":"Can J Gastroenterol Hepatol"}],"container-title":["Journal of the Canadian Association of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcag\/article-pdf\/2\/4\/161\/30124364\/gwy042.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcag\/article-pdf\/2\/4\/161\/30124364\/gwy042.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T23:13:00Z","timestamp":1720393980000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcag\/article\/2\/4\/161\/5055329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,18]]},"references-count":93,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,7,18]]},"published-print":{"date-parts":[[2019,10,9]]}},"URL":"https:\/\/doi.org\/10.1093\/jcag\/gwy042","relation":{},"ISSN":["2515-2084","2515-2092"],"issn-type":[{"value":"2515-2084","type":"print"},{"value":"2515-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,12]]},"published":{"date-parts":[[2018,7,18]]}}}